EGFR and glioblastoma: It’s interesting to note that our proteome and transcriptome results also indicated that the expression of EGFR, the most commonly altered gene in GBM with overexpression and/or mutation occurring in at least 50% of cases [46], was not significantly different between the tumor group and the astrocyte group.